Why financial hardship is more likely if you’re disabled or sick 
Oil Prices Slip as U.S.-Iran Tensions and Ceasefire Uncertainty Weigh on Markets 
Huawei Expands Vietnam Presence Through Strategic Partnership with SHB Bank 
Australia Extends Fuel Sulphur Relaxation Amid Iran War Supply Disruptions 
U.S. Stock Futures Fall as Iran Tensions Escalate and Oil Prices Surge 
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims 
Asian Stocks Rise as Tech Gains Offset US-Iran Tensions, Oil Prices Add Pressure 
Apple Wins ITC Ruling, Keeping Blood-Oxygen Feature on Apple Watch 
Democratic Attorneys General Sue Trump Administration Over CDC Childhood Vaccine Schedule Changes 
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment 
Energy Price Spike Won't Trigger Lasting Inflation, Analysts Say 
UK Wage Growth Slows to 3.6% as Inflation Pressures Complicate Bank of England Outlook 
How Technology Is Reshaping Modern Business: From Operations to Customer Experience 
US Dollar Slips Amid Iran Tensions and Fed Leadership Uncertainty 
Chinese Robotics Stocks React as Humanoid Robot Marathon Sparks Competition Concerns 
Want to cut your energy bills? Here’s how five experts are doing it 
Bubs Australia will manufacture and distribute Bubs’ Chinese-label goat milk infant formula in China according to new Chinese standards. under an agreement with Heilongjiang Ubeite Dairy Group (HUG).
The new standards will come into effect in February 2023 .
The “ultra-premium” infant formula has been specially developed for Chinese infants using easily-digestible A2 goat-milk protein, sn2 palmitate (OPO), lactoferrin prebiotics, and nucleotides.
HUG has started submission with the State Administration for Market Regulation (SAMR) to renew its registration in line with China’s new GB standards for exclusive use under the Bubs brand.
According to Kristy Carr, Bubs founder and CEO, they have built strong brand trust and loyalty with Chinese families through marketing and selling Bubs English label infant formula products via the crossborder eCommerce channel, which accounts for around 20 percent of total Chinese infant formula sales.
If approved by SAMR, the formula will give Bubs access to the remaining 80 percent of China’s $25.9 billion infant formula market.
Bubs will also enter into a joint venture agreement, where it will hold a 75 percent interest, with Zhitong Health Technology to distribute its Chinese label goat infant formula products.
Bubs Australia expects to launch its product in the second half of FY23, subject to receiving SAMR approval.
